Galapagos NV
GLPG
#4624
Rank
โ‚น185.03 B
Marketcap
โ‚น2,808
Share price
-0.10%
Change (1 day)
22.88%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): -โ‚น34.67

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -โ‚น30.64. In 2024 the company made an earnings per share (EPS) of โ‚น105.30 a decrease over its 2023 EPS that were of โ‚น320.60.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น34.67-132.92%
2024โ‚น105.30-67.16%
2023โ‚น320.60-199.64%
2022-โ‚น321.7599.03%
2021-โ‚น161.66-68.98%
2020-โ‚น521.18-298.06%
2019โ‚น263.15-554.64%
2018-โ‚น57.88-77.18%
2017-โ‚น253.66-326.21%
2016โ‚น112.14-134.19%
2015-โ‚น327.97-371.34%
2014โ‚น120.87-445.98%
2013-โ‚น34.9432.88%
2012-โ‚น26.29-82.07%
2011-โ‚น146.66-817.9%
2010โ‚น20.4312.73%
2009โ‚น18.12-120.79%
2008-โ‚น87.15-37.67%
2007-โ‚น139.8339.64%
2006-โ‚น100.1428.17%
2005-โ‚น78.136.25%
2004-โ‚น73.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
AstraZeneca
AZN
โ‚น274.20-994.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
โ‚น943.17-3,178.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น334.80-1,192.75%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
โ‚น122.14-498.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
-โ‚น55.11 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น727.93-2,475.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น56.92-285.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
โ‚น324.88-1,160.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚น686.08-2,339.29%๐Ÿ‡บ๐Ÿ‡ธ USA